Boya Bio-Pharmaceutical shareholders approve profit distribution, elect new directors

CR Boya Bio-Pharmaceutical Group held its first extraordinary general meeting of 2025 on September 12, 2025. The meeting, held in Fuzhou City, Jiangxi Province, saw 222 shareholders, representing 43.8250% of total voting shares, participate through in-person attendance and online voting.

Key proposals were approved, including the 2025 half-year profit distribution plan and the election of new non-independent directors. The profit distribution proposal passed with 99.5196% of votes in favor, with strong support from small and medium investors.

Shareholders also approved the election of Lin Peng and Wang Yifei as non-independent directors. Both individuals were successfully appointed to the board. The meeting's procedures and results were deemed legally valid.